Skip to content
Defeat Duchenne Canada Logo

Open Access: Recent studies on Duchenne muscular dystrophy

March 15, 2021

Recent studies on Duchenne muscular dystrophy (DMD) have greatly deepened our understanding of the primary and secondary pathogenetic mechanisms. Guidelines for the multidisciplinary care for Duchenne that address obtaining a genetic diagnosis and managing the various aspects of the disease have been established.

In addition, a number of therapies that aim to restore the missing dystrophin protein or address secondary pathology have received regulatory approval and many others are in clinical development.

This open-access Nature article by Defeat Duchenne Canada funded researcher, Dongsheng Duan, along with Nathalie Goemans, Shin’ichi Takeda, Eugenio Mercuri and Annemieke Aartsma-Rus discusses all the topics mentioned above.

Click here to read the full article on